108 related articles for article (PubMed ID: 35550518)
21. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
[TBL] [Abstract][Full Text] [Related]
22. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors.
Parker SL; Parker MS; Crowley WR
Regul Pept; 1998 Sep; 75-76():127-43. PubMed ID: 9802402
[TBL] [Abstract][Full Text] [Related]
24. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
25. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system.
Naveilhan P; Neveu I; Arenas E; Ernfors P
Neuroscience; 1998 Nov; 87(1):289-302. PubMed ID: 9722158
[TBL] [Abstract][Full Text] [Related]
26. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
27. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
[TBL] [Abstract][Full Text] [Related]
28. Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat.
Jinde S; Masui A; Morinobu S; Noda A; Kato N
Neuroscience; 2002; 115(4):1035-45. PubMed ID: 12453477
[TBL] [Abstract][Full Text] [Related]
29. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice.
Fukasaka Y; Nambu H; Tanioka H; Obata A; Tonomura M; Okuno T; Yukioka H
Neuropeptides; 2018 Aug; 70():55-63. PubMed ID: 29801968
[TBL] [Abstract][Full Text] [Related]
30. Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.
Nichol KA; Morey A; Couzens MH; Shine J; Herzog H; Cunningham AM
J Neurosci; 1999 Dec; 19(23):10295-304. PubMed ID: 10575027
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
32. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
Yannielli PC; Harrington ME
J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y stimulates food consumption through multiple receptors in goldfish.
Narnaware YK; Peter RE
Physiol Behav; 2001 Sep 1-15; 74(1-2):185-90. PubMed ID: 11564467
[TBL] [Abstract][Full Text] [Related]
34. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes.
Wyss P; Stricker-Krongrad A; Brunner L; Miller J; Crossthwaite A; Whitebread S; Criscione L
Regul Pept; 1998 Sep; 75-76():363-71. PubMed ID: 9802430
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
36. Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study.
Jacques D; Tong Y; Shen SH; Quirion R
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):100-7. PubMed ID: 9795164
[TBL] [Abstract][Full Text] [Related]
37. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.
Son MY; Kim MJ; Yu K; Koo DB; Cho YS
J Cell Mol Med; 2011 Jan; 15(1):152-65. PubMed ID: 19874423
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
39. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
40. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
